The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Pooled analyses after long-term follow-up in KEYNOTE-012.
 
Ranee Mehra
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - Genentech
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Tanguy Y. Seiwert
Honoraria - Amgen; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Merck; Merck Serono
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst)
 
Amit Mahipal
No Relationships to Disclose
 
Jared Weiss
Consulting or Advisory Role - AstraZeneca; Biodesix; Clovis Oncology; EMD Serono; Lilly; OncoPlex Diagnostics
Research Funding - Astellas Pharma (Inst); Celgene (Inst); MedImmune (Inst); Merck (Inst); novartis (Inst); Pfizer (Inst)
 
Raanan Berger
No Relationships to Disclose
 
Joseph Paul Eder
Honoraria - Merck
Travel, Accommodations, Expenses - Merck
 
Barbara Burtness
Consulting or Advisory Role - MedImmune; Merck; Novartis; VentiRx
Research Funding - Genentech; Merck
Expert Testimony - Johnson & Johnson
 
Makoto Tahara
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Merck Serono; Otsuka
Consulting or Advisory Role - Bayer; MSD; Ono Pharmaceutical; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); NanoCarrier (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
Bhumsuk Keam
No Relationships to Disclose
 
Dung T. Le
Honoraria - Merck
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Merck
 
Kei Muro
Honoraria - Chugai Pharma; Takeda; Yakult Honsha
Consulting or Advisory Role - Takeda
 
Ravit Geva
No Relationships to Disclose
 
Hyun Cheol Chung
Consulting or Advisory Role - Celltrion; Lilly; Merck; MSD; Quintiles; Taiho Pharmaceutical
Speakers' Bureau - Lilly; Merck
Research Funding - GlaxoSmithKline; Lilly
 
Chia-Chi Lin
No Relationships to Disclose
 
Amy Meister
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Darcy Hille
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jonathan D. Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Laura Quan Man Chow
Honoraria - Amgen; Astellas Pharma; Emergent BioSolutions; Merck; Novartis
Consulting or Advisory Role - Amgen; Emergent BioSolutions; Merck; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Lilly/ImClone (Inst); Merck (Inst); NCCN/Glaxo-Smith Kline (Inst); Novartis (Inst); Pfizer (Inst); VentiRx (Inst)
Travel, Accommodations, Expenses - Merck; Novartis
 
Robert I. Haddad
Consulting or Advisory Role - Bayer; Celgene; Eisai; Merck
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)